Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Contraction Timing Patterns in Patients Treated for Breast Cancer Before and After Anthracyclines Therapy.

Cheng KH, Handschumacher MD, Assuncao BM, Sebag IA, Halpern EF, Scherrer-Crosbie M.

J Am Soc Echocardiogr. 2017 Mar 2. pii: S0894-7317(16)30761-1. doi: 10.1016/j.echo.2016.12.013. [Epub ahead of print]

PMID:
28262302
2.

In vivo assessment of aortic root geometry in normal controls using 3D analysis of computed tomography.

Yang DH, Kim DH, Handschumacher MD, Levine RA, Kim JB, Sun BJ, Jang JY, Kim N, Baek S, Kang JW, Song JM, Kang DH, Lim TH, Song JK.

Eur Heart J Cardiovasc Imaging. 2016 Jul 26. pii: jew146. [Epub ahead of print]

PMID:
27461206
3.

Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve.

Dal-Bianco JP, Aikawa E, Bischoff J, Guerrero JL, Hjortnaes J, Beaudoin J, Szymanski C, Bartko PE, Seybolt MM, Handschumacher MD, Sullivan S, Garcia ML, Mauskapf A, Titus JS, Wylie-Sears J, Irvin WS, Chaput M, Messas E, Hagège AA, Carpentier A, Levine RA; Leducq Transatlantic Mitral Network..

J Am Coll Cardiol. 2016 Jan 26;67(3):275-87. doi: 10.1016/j.jacc.2015.10.092.

4.

Mitral valve disease--morphology and mechanisms.

Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, Song JK, Yacoub MH; Leducq Mitral Transatlantic Network..

Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Review.

5.

Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension.

Afilalo J, Grapsa J, Nihoyannopoulos P, Beaudoin J, Gibbs JS, Channick RN, Langleben D, Rudski LG, Hua L, Handschumacher MD, Picard MH, Levine RA.

Circ Cardiovasc Imaging. 2015 May;8(5). pii: e002714. doi: 10.1161/CIRCIMAGING.114.002714.

6.

Efficacy of polymer injection for ischemic mitral regurgitation: persistent reduction of mitral regurgitation and attenuation of left ventricular remodeling.

Zeng X, Zou L, Levine RA, Guerrero JL, Handschumacher MD, Sullivan SM, Braithwaite GJ, Stone JR, Solis J, Muratoglu OK, Vlahakes GJ, Hung J.

JACC Cardiovasc Interv. 2015 Feb;8(2):355-63. doi: 10.1016/j.jcin.2014.09.016.

7.

Basic mechanisms of mitral regurgitation.

Dal-Bianco JP, Beaudoin J, Handschumacher MD, Levine RA.

Can J Cardiol. 2014 Sep;30(9):971-81. doi: 10.1016/j.cjca.2014.06.022. Review.

8.

Aortic valve adaptation to aortic root dilatation: insights into the mechanism of functional aortic regurgitation from 3-dimensional cardiac computed tomography.

Kim DH, Handschumacher MD, Levine RA, Sun BJ, Jang JY, Yang DH, Kang JW, Song JM, Kang DH, Lim TH, Song JK.

Circ Cardiovasc Imaging. 2014 Sep;7(5):828-35. doi: 10.1161/CIRCIMAGING.113.001976.

9.

Role of LA shape in predicting embolic cerebrovascular events in mitral stenosis: mechanistic insights from 3D echocardiography.

Nunes MC, Handschumacher MD, Levine RA, Barbosa MM, Carvalho VT, Esteves WA, Zeng X, Guerrero JL, Zheng H, Tan TC, Hung J.

JACC Cardiovasc Imaging. 2014 May;7(5):453-61. doi: 10.1016/j.jcmg.2014.01.013.

10.

The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty.

Nunes MC, Tan TC, Elmariah S, do Lago R, Margey R, Cruz-Gonzalez I, Zheng H, Handschumacher MD, Inglessis I, Palacios IF, Weyman AE, Hung J.

Circulation. 2014 Feb 25;129(8):886-95. doi: 10.1161/CIRCULATIONAHA.113.001252.

11.

Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repair.

Beaudoin J, Levine RA, Guerrero JL, Yosefy C, Sullivan S, Abedat S, Handschumacher MD, Szymanski C, Gilon D, Palmeri NO, Vlahakes GJ, Hajjar RJ, Beeri R.

Circulation. 2013 Sep 10;128(11 Suppl 1):S248-52. doi: 10.1161/CIRCULATIONAHA.112.000124.

12.

Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial).

Golba K, Mokrzycki K, Drozdz J, Cherniavsky A, Wrobel K, Roberts BJ, Haddad H, Maurer G, Yii M, Asch FM, Handschumacher MD, Holly TA, Przybylski R, Kron I, Schaff H, Aston S, Horton J, Lee KL, Velazquez EJ, Grayburn PA; STICH TEE Substudy Investigators..

Am J Cardiol. 2013 Dec 1;112(11):1812-8. doi: 10.1016/j.amjcard.2013.07.047.

13.

Assessment of mitral valve adaptation with gated cardiac computed tomography: validation with three-dimensional echocardiography and mechanistic insight to functional mitral regurgitation.

Beaudoin J, Thai WE, Wai B, Handschumacher MD, Levine RA, Truong QA.

Circ Cardiovasc Imaging. 2013 Sep;6(5):784-9. doi: 10.1161/CIRCIMAGING.113.000561.

14.

Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle.

Beaudoin J, Handschumacher MD, Zeng X, Hung J, Morris EL, Levine RA, Schwammenthal E.

J Am Coll Cardiol. 2013 Apr 30;61(17):1809-16. doi: 10.1016/j.jacc.2013.01.064.

15.

Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling.

Szymanski C, Bel A, Cohen I, Touchot B, Handschumacher MD, Desnos M, Carpentier A, Menasché P, Hagège AA, Levine RA, Messas E; Leducq Foundation MITRAL Transatlantic Network..

Circulation. 2012 Dec 4;126(23):2720-7. doi: 10.1161/CIRCULATIONAHA.111.033472.

16.

Persistence of mitral regurgitation following ring annuloplasty: is the papillary muscle outside or inside the ring?

Hung J, Solis J, Handschumacher MD, Guerrero JL, Levine RA.

J Heart Valve Dis. 2012 Mar;21(2):218-24.

17.

Impact of mitral regurgitation on exercise capacity and clinical outcomes in patients with ischemic left ventricular dysfunction.

Szymanski C, Levine RA, Tribouilloy C, Zheng H, Handschumacher MD, Tawakol A, Hung J.

Am J Cardiol. 2011 Dec 15;108(12):1714-20. doi: 10.1016/j.amjcard.2011.07.045.

18.

Myocardial viability and survival in ischemic left ventricular dysfunction.

Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA; STICH Trial Investigators..

N Engl J Med. 2011 Apr 28;364(17):1617-25. doi: 10.1056/NEJMoa1100358.

19.

Coronary-artery bypass surgery in patients with left ventricular dysfunction.

Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; STICH Investigators..

N Engl J Med. 2011 Apr 28;364(17):1607-16. doi: 10.1056/NEJMoa1100356.

20.

Mitral regurgitation after anteroapical myocardial infarction: new mechanistic insights.

Yosefy C, Beeri R, Guerrero JL, Vaturi M, Scherrer-Crosbie M, Handschumacher MD, Levine RA.

Circulation. 2011 Apr 12;123(14):1529-36. doi: 10.1161/CIRCULATIONAHA.110.977843.

Supplemental Content

Loading ...
Support Center